<table border="0" cellpadding="0" cellspacing="0" width="895" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8: Mean ± SD Levofloxacin PK Parameters  
</caption>
<tbody>
<tr>
<th colspan="1">Regimen</th>
<th colspan="1">C<sub>max</sub>
<br/>(mcg/mL)</th>
<th colspan="1">T<sub>max</sub>
<br/>(h)</th>
<th colspan="1">AUC<br/>(mcg•h/mL) </th>
<th colspan="1">CL/F<sup>1</sup>
<br/>(mL/min) </th>
<th colspan="1">Vd/F<sup>2</sup>
<br/>(L)</th>
<th colspan="1">t<sub>1/2</sub>
<br/>(h)</th>
<th colspan="1">CL<sub>R</sub>
<br/>(mL/min) </th>
</tr>
<tr>
<td>
<content stylecode="bold">   Single dose </content>
<br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
</tr>
<tr>
<td>   250 mg oral tablet<sup>3</sup>
<br/>
</td>
<td>2.8 ± 0.4<br/>
</td>
<td>1.6 ± 1<br/>
</td>
<td>27.2 ± 3.9<br/>
</td>
<td>156 ± 20<br/>
</td>
<td>ND<br/>
</td>
<td>7.3 ± 0.9 <br/>
</td>
<td>142 ± 21<br/>
</td>
</tr>
<tr>
<td>   500 mg oral tablet<sup>3*</sup>
<br/>
</td>
<td>5.1 ± 0.8<br/>
</td>
<td>1.3 ± 0.6<br/>
</td>
<td>47.9 ± 6.8<br/>
</td>
<td>178 ± 28 <br/>
</td>
<td>ND<br/>
</td>
<td>6.3 ± 0.6<br/>
</td>
<td>103 ± 30<br/>
</td>
</tr>
<tr>
<td>   500 mg oral solution<sup>12</sup>
<br/>
</td>
<td>5.8 ± 1.8<br/>
</td>
<td>0.8 ± 0.7 <br/>
</td>
<td>47.8 ± 10.8<br/>
</td>
<td>183 ± 40<br/>
</td>
<td>112 ± 37.2 <br/>
</td>
<td>7 ± 1.4<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>   500 mg IV<sup>3</sup>
<br/>
</td>
<td>6.2 ± 1<br/>
</td>
<td>1 ± 0.1<br/>
</td>
<td>48.3 ± 5.4<br/>
</td>
<td>175 ± 20<br/>
</td>
<td>90 ± 11<br/>
</td>
<td>6.4 ± 0.7 <br/>
</td>
<td>112 ± 25<br/>
</td>
</tr>
<tr>
<td>   750 mg oral tablet<sup>5*</sup>
<br/>
</td>
<td>9.3 ± 1.6<br/>
</td>
<td>1.6 ± 0.8<br/>
</td>
<td>101 ± 20<br/>
</td>
<td>129 ± 24<br/>
</td>
<td>83 ± 17<br/>
</td>
<td>7.5 ± 0.9<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>   750 mg IV<sup>5</sup>
<br/>
</td>
<td>11.5 ± 4<sup>4 </sup>
<br/>
</td>
<td>ND<br/>
</td>
<td>110 ± 40<br/>
</td>
<td>126 ± 39<br/>
</td>
<td>75 ± 13<br/>
</td>
<td>7.5 ± 1.6<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">   Multiple dose </content>
<br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
</tr>
<tr>
<td>   500 mg every 24 h oral tablet<sup>3</sup>
<br/>
</td>
<td>5.7 ± 1.4<br/>
</td>
<td>1.1 ± 0.4<br/>
</td>
<td>47.5 ± 6.7<br/>
</td>
<td>175 ± 25<br/>
</td>
<td>102 ± 22<br/>
</td>
<td>7.6 ± 1.6<br/>
</td>
<td>116 ± 31<br/>
</td>
</tr>
<tr>
<td>   500 mg every 24 h IV<sup>3</sup>
<br/>
</td>
<td>6.4 ± 0.8<br/>
</td>
<td>ND<br/>
</td>
<td>54.6 ± 11.1<br/>
</td>
<td>158 ± 29<br/>
</td>
<td>91 ± 12<br/>
</td>
<td>7 ± 0.8<br/>
</td>
<td>99 ± 28<br/>
</td>
</tr>
<tr>
<td>   500 mg or 250 mg every 24 h IV, patients with bacterial infection<sup>6 </sup>
<br/>
</td>
<td>8.7 ± 4<sup>7</sup>
<br/>
</td>
<td>ND<br/>
</td>
<td>72.5 ± 51.2<sup>7</sup>
<br/>
</td>
<td>154 ± 72<br/>
</td>
<td>111 ± 58<br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>   750 mg every 24 h oral tablet<sup>5</sup>
<br/>
</td>
<td>8.6 ± 1.9<br/>
</td>
<td>1.4 ± 0.5<br/>
</td>
<td>90.7 ± 17.6<br/>
</td>
<td>143 ± 29<br/>
</td>
<td>100 ± 16<br/>
</td>
<td>8.8 ± 1.5<br/>
</td>
<td>116 ± 28<br/>
</td>
</tr>
<tr>
<td>   750 mg every 24 h IV<sup>5</sup>
<br/>
</td>
<td>12.1 ± 4.1<sup>4 </sup>
<br/>
</td>
<td>ND<br/>
</td>
<td>108 ± 34<br/>
</td>
<td>126 ± 37<br/>
</td>
<td>80 ± 27<br/>
</td>
<td>7.9 ± 1.9<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">   500 mg oral tablet single dose, effects of gender and age: </content>
<br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
</tr>
<tr>
<td>   Male<sup>8</sup>
<br/>
</td>
<td>5.5 ± 1.1<br/>
</td>
<td>1.2 ± 0.4<br/>
</td>
<td>54.4 ± 18.9<br/>
</td>
<td>166 ± 44<br/>
</td>
<td>89 ± 13<br/>
</td>
<td>7.5 ± 2.1<br/>
</td>
<td>126 ± 38<br/>
</td>
</tr>
<tr>
<td>   Female<sup>9</sup>
<br/>
</td>
<td>7 ± 1.6<br/>
</td>
<td>1.7 ± 0.5<br/>
</td>
<td>67.7 ± 24.2<br/>
</td>
<td>136 ± 44<br/>
</td>
<td>62 ± 16<br/>
</td>
<td>6.1 ± 0.8<br/>
</td>
<td>106 ± 40<br/>
</td>
</tr>
<tr>
<td>   Young<sup>10</sup>
<br/>
</td>
<td>5.5 ± 1<br/>
</td>
<td>1.5 ± 0.6<br/>
</td>
<td>47.5 ± 9.8<br/>
</td>
<td>182 ± 35<br/>
</td>
<td>83 ± 18<br/>
</td>
<td>6 ± 0.9<br/>
</td>
<td>140 ± 33<br/>
</td>
</tr>
<tr>
<td>   Elderly<sup>11</sup>
<br/>
</td>
<td>7 ± 1.6<br/>
</td>
<td>1.4 ± 0.5<br/>
</td>
<td>74.7 ± 23.3<br/>
</td>
<td>121 ± 33<br/>
</td>
<td>67 ± 19<br/>
</td>
<td>7.6 ± 2<br/>
</td>
<td>91 ± 29<br/>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">   500 mg oral single dose tablet, patients with renal insufficiency: </content>
<br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
<td> <br/>
</td>
</tr>
<tr>
<td>   CLCR 50 to 80 mL/min <br/>
</td>
<td>7.5 ± 1.8<br/>
</td>
<td>1.5 ± 0.5<br/>
</td>
<td>95.6 ± 11.8<br/>
</td>
<td>88 ± 10<br/>
</td>
<td>ND<br/>
</td>
<td>9.1 ± 0.9<br/>
</td>
<td>57 ± 8<br/>
</td>
</tr>
<tr>
<td>   CLCR 20 to 49 mL/min <br/>
</td>
<td>7.1 ± 3.1<br/>
</td>
<td>2.1 ± 1.3<br/>
</td>
<td>182.1 ± 62.6<br/>
</td>
<td>51 ± 19<br/>
</td>
<td>ND<br/>
</td>
<td>27 ± 10<br/>
</td>
<td>26 ± 13<br/>
</td>
</tr>
<tr>
<td>   CLCR &lt;20 mL/min <br/>
</td>
<td>8.2 ± 2.6<br/>
</td>
<td>1.1 ± 1<br/>
</td>
<td>263.5 ± 72.5<br/>
</td>
<td>33 ± 8<br/>
</td>
<td>ND<br/>
</td>
<td>35 ± 5<br/>
</td>
<td>13 ± 3<br/>
</td>
</tr>
<tr>
<td>   Hemodialysis <br/>
</td>
<td>5.7 ± 1<br/>
</td>
<td>2.8 ± 2.2<br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
<td>76 ± 42<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>   CAPD <br/>
</td>
<td>6.9 ± 2.3<br/>
</td>
<td>1.4 ± 1.1<br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
<td>51 ± 24<br/>
</td>
<td>ND<br/>
</td>
</tr>
</tbody>
</table>